M&A News: Bain Capital Buys 350-Year-Old Japanese Drugs Firm for $3.4 billion
Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...
Axios on MSN1d
Bain may bail on Fuji Soft pursuit, after new KKR bid
Bain Capital disclosed that it is considering the "option of withdrawing" its hostile $4.2 billion takeover bid for Japanese ...
Bain Capital Ventures-backed startup Index raises $2 million to build product management tools
The Australia-based startup gets seed funding to enhance product management tools, facilitating idea tracking and roadmap ...
BioSpace2d
Bain Bets Big on Japanese Market With $3.3B Tanabe Buy
The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences ...
Exclusive-Buyout firms vie for cybersecurity firm Trend Micro, sources say
Bain Capital, Advent International and EQT AB are among the private equity firms competing to acquire Japanese cybersecurity ...
Plastics News7d
Hillenbrand sells majority stake in Milacron to Bain Capital for $287M
Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...
Bain Capital buys Japanese pharma for $3.3B
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
Business Wire7d
Bain Capital Announces Majority Investment in Milacron, a Leading Global Provider of Highly Engineered Plastic Processing Solutions
BOSTON & BATESVILLE, Ind.--(BUSINESS WIRE)--Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the ...